Evidence map›Paper›PMID 8901600›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.

H Azuma, A Chandraker, K Nadeau, W W Hancock, C B Carpenter, N L Tilney, M H Sayegh

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 167 citations in OpenAlex.

  1. Animal models for transplant immunology: bridging bench to bedside.Clinical transplantation and research · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Experimental rat models of chronic allograft nephropathy: a review.International journal of nephrology and renovascular disease · 2014
    Review
  9. Review
  10. T-cell costimulatory blockade in organ transplantation.Cold Spring Harbor perspectives in medicine · 2013
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Review
  16. T-cell activation and transplantation tolerance.Transplantation reviews (Orlando, Fla.) · 2012
    Review
  17. Article
  18. Article
  19. Article
  20. Costimulatory pathways in transplantation.Seminars in immunology · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

H AzumaBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
A Chandraker
K Nadeau
W W Hancock
C B Carpenter
N L Tilney
M H Sayegh
Harvard University · USBrigham and Women's Hospital · US

Funding

RENAL EFFECTS OF BRAIN DEATH AND THE MARGINAL DONORR01DK046190 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI TILNEY, NICHOLAS L · 1992 to 1999
–
INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDESR29AI034965 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SAYEGH, MOHAMED H · 1994 to 1998
–
NIAID NIH HHS R01AI-31100NIAID NIH HHS R29AI-34965NIDDK NIH HHS R01DK-46190
6 · The paper itself

Abstract

Blocking CD28-B7 T-cell costimulation by systemic administration of CTLA4Ig, a fusion protein which binds B7 molecules on the surface of antigen-presenting cells, prevents rejection and induces tolerance in experimental acute allograft rejection models. We tested the effect of CTLA4Ig therapy on the process of chronic renal allograft rejection using an established experimental transplantation model. F344 kidneys were transplanted orthotopically into bilaterally nephrectomized LEW recipients. Control animals received low dose cyclosporine for 10 days posttransplantation. Administration of a single injection of CTLA4Ig on day 2 posttransplant alone or in addition to the low dose cyclosporine protocol resulted in improvement of long-term graft survival as compared with controls. More importantly, control recipients which received cyclosporine only developed progressive proteinuria by 8-12 weeks, and morphological evidence of chronic rejection by 16-24 weeks, including widespread transplant arteriosclerosis and focal and segmental glomerulosclerosis, while animals treated with CTLA4Ig alone or in addition to cyclosporine did not. Competitive reverse transcriptase-PCR and immunohistological analysis of allografts at 8, 16, and 24 weeks showed attenuation of lymphocyte and macrophage infiltration and activation in the CTLA4Ig-treated animals, as compared with cyclosporine-alone treated controls. These data confirm that early blockade of the CD28-B7 T-cell costimulatory pathway prevents later development and evolution of chronic renal allograft rejection. Our results indicate that T-cell recognition of alloantigen is a central event in initiating the process of chronic rejection, and that strategies targeted at blocking T-cell costimulation may prove to be a valuable clinical approach to preventing development of the process.

Indexed as

ImmunoconjugatesAbataceptAnimalsAntigens, CDAntigens, DifferentiationCTLA-4 AntigenCyclosporineDisease Models, AnimalGraft RejectionImmunosuppressive AgentsIsoantigensKidney TransplantationMacrophagesMaleProteinuriaRatsAbataceptAntigens, CDAntigens, DifferentiationCTLA-4 AntigenCyclosporineImmunoconjugatesImmunosuppressive AgentsIsoantigens

Identifiers

PMID8901600
PMCPMC38010
OpenAlexW2076212710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.